MedPath

FLONASE AEM-SUS 50MCG/AEM

FLONASE AEM-SUS 50MCG/AEM

Discontinued
DIN Number

02048043

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

glaxo canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02048043
AIG Number0124685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD08 FLUTICASONE
Product Specifications
Dosage FormSuspension ,  Metered-Dose Aerosol
Route of AdministrationNasal
AHFS Classification52:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.